Internal Medicine, Hematology & Oncology · Fayetteville, AR
NPI
1083685283
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3232 N Northhills Blvd
Fayetteville, AR, 72703
Phone (479) 587-1700
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.9M
267,464 services
Medicare patients, 2024
1,611
Average age 74
Drug cost, 2024
$6.4M
1,947 prescriptions
Company payments, 2025
$4,713
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephan B Rosenfeld was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 30,690 times for 233 patients. In total Stephan B Rosenfeld billed 267,464 services in 319 codes, and Medicare paid $4.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-06.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 30,690 | 233 | $0.10 | $3,060 |
| J9299 Injection, nivolumab, 1 mg | Office | 17,960 | 21 | $24.52 | $440K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 17,340 | 31 | $0.27 | $4,756 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 16,200 | 37 | $44.17 | $716K |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 15,961 | 29 | $0.36 | $5,670 |
| J9267 Injection, paclitaxel, 1 mg | Office | 10,515 | 31 | $0.08 | $811 |
| A9575 Injection, gadoterate meglumine, 0.1 ml | Office | 10,330 | 54 | $0.09 | $962 |
| J0897 Injection, denosumab, 1 mg | Office | 9,660 | 81 | $20.52 | $198K |
| J1071 Injection, testosterone cypionate, 1 mg | Office | 7,000 | 11 | $0.02 | $110 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,900 | 27 | $0.11 | $752 |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 5,540 | 39 | $38.61 | $214K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 3,656 | 41 | $6.42 | $23K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,202 | 147 | $0.09 | $279 |
| Q5126 Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg | Office | 2,610 | 13 | $45.94 | $120K |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 2,160 | 15 | $31.49 | $68K |
By year: 2022 $5.6M for 343,794 services; 2023 $4.3M for 287,445 services; 2024 $4.9M for 267,464 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,079 | 840 | $7.55 | $16K |
| 80053 Clinical Chemistry | 1,520 | 611 | $10.27 | $16K |
| 84550 Clinical Chemistry | 1,480 | 566 | $4.39 | $6,498 |
| 84100 Clinical Chemistry | 1,462 | 564 | $4.61 | $6,737 |
| 83735 Clinical Chemistry | 1,462 | 567 | $6.51 | $9,514 |
| 82248 Clinical Chemistry | 1,455 | 562 | $4.88 | $7,107 |
| 83615 Clinical Chemistry | 1,453 | 560 | $5.87 | $8,523 |
| 86300 Immunoassay | 318 | 226 | $20.31 | $6,458 |
| 82728 Clinical Chemistry | 271 | 188 | $13.33 | $3,611 |
| 83540 Clinical Chemistry | 264 | 182 | $6.32 | $1,669 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephan B Rosenfeld prescribed most often to Medicare patients was Letrozole, with 535 prescriptions and refills. In total Stephan B Rosenfeld wrote 1,947 Medicare prescriptions that cost $6.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 535 | 1,384 | 175 | $10K |
| Ibrance Palbociclib | 142 | 142 | 15 | $2.3M |
| Tamoxifen Citrate Generic | 118 | 289 | 42 | $2,804 |
| Ondansetron Odt Ondansetron | 69 | 69 | 46 | $1,142 |
| Hydroxyurea Generic | 57 | 105 | 13 | $950 |
| Anastrozole Generic | 54 | 136 | 22 | $1,355 |
| Prochlorperazine Maleate Generic | 51 | 51 | 33 | $1,379 |
| Oxycodone Hcl Generic | 45 | 46 | 26 | $498 |
| Imbruvica Ibrutinib | 43 | 43 | Under 11 | $704K |
| Levofloxacin Generic | 37 | 37 | 32 | $86.95 |
| Calquence Acalabrutinib Maleate | 33 | 33 | Under 11 | $497K |
| Eliquis Apixaban | 30 | 36 | Under 11 | $21K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 27 | 27 | 22 | $373 |
| Pantoprazole Sodium Generic | 25 | 47 | Under 11 | $106 |
| Prednisone Generic | 24 | 30 | 19 | $67.72 |
Brand drugs: 433 claims; generic drugs: 1,514 claims; opioid claims: 109.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephan B Rosenfeld $4,713 ($4,713 in general payments such as food, travel and fees) from 25 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,744.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $1,744 |
| Incyte Corporation INCY | 2 | $873 |
| Daiichi Sankyo Inc. 4568.T | 8 | $805 |
| Cardinal Health 110 LLC | 1 | $275 |
| Puma Biotechnology, Inc. PBYI | 11 | $162 |
| Merck Sharp & Dohme LLC MRK | 9 | $152 |
| Abbvie Inc. ABBV | 6 | $100 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $89.41 |
| Stemline Therapeutics Inc. | 4 | $72.81 |
| Iovance Biotherapeutics, Inc. IOVA | 4 | $57.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.